These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 21741199
1. Predictors of clinical outcomes of resected ampullary adenocarcinoma: a single-institution experience. Lazaryan A, Kalmadi S, Almhanna K, Pelley R, Kim R. Eur J Surg Oncol; 2011 Sep; 37(9):791-7. PubMed ID: 21741199 [Abstract] [Full Text] [Related]
3. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. Kim RD, Kundhal PS, McGilvray ID, Cattral MS, Taylor B, Langer B, Grant DR, Zogopoulos G, Shah SA, Greig PD, Gallinger S. J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504 [Abstract] [Full Text] [Related]
7. Pattern analysis of lymph node metastasis and the prognostic importance of number of metastatic nodes in ampullary adenocarcinoma. Lee JH, Lee KG, Ha TK, Jun YJ, Paik SS, Park HK, Lee KS. Am Surg; 2011 Mar; 77(3):322-9. PubMed ID: 21375845 [Abstract] [Full Text] [Related]
8. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma. Tomazic A, Pegan V, Ferlan-Marolt K, Pleskovic A, Luzar B. Hepatogastroenterology; 2004 Mar; 51(60):1832-7. PubMed ID: 15532837 [Abstract] [Full Text] [Related]
9. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma. Barauskas G, Gulbinas A, Pranys D, Dambrauskas Z, Pundzius J. J Hepatobiliary Pancreat Surg; 2008 Mar; 15(4):423-8. PubMed ID: 18670845 [Abstract] [Full Text] [Related]
10. Pancreaticoduodenectomy for periampullary adenocarcinoma. Andersen HB, Baden H, Brahe NE, Burcharth F. J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456 [Abstract] [Full Text] [Related]
13. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery. Uchida H, Shibata K, Iwaki K, Kai S, Ohta M, Kitano S. Hepatogastroenterology; 2009 Nov; 56(93):1194-8. PubMed ID: 19760968 [Abstract] [Full Text] [Related]
14. Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater. van der Gaag NA, ten Kate FJ, Lagarde SM, Busch OR, van Gulik TM, Gouma DJ. Br J Surg; 2008 Jun; 95(6):735-43. PubMed ID: 18300268 [Abstract] [Full Text] [Related]
15. Survival after resection of ampullary carcinoma: a national population-based study. O'Connell JB, Maggard MA, Manunga J, Tomlinson JS, Reber HA, Ko CY, Hines OJ. Ann Surg Oncol; 2008 Jul; 15(7):1820-7. PubMed ID: 18369675 [Abstract] [Full Text] [Related]
16. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma. Wang CH, Mo LR, Lin RC, Kuo JJ, Chang KK, Lin YW, Yang DM, Yau MP, Cho CY. Hepatogastroenterology; 2004 Jul; 51(59):1495-9. PubMed ID: 15362785 [Abstract] [Full Text] [Related]
17. Long-term results of surgical treatment of Vater's ampulla neoplasms. Bucher P, Chassot G, Durmishi Y, Ris F, Morel P. Hepatogastroenterology; 2007 Jun; 54(76):1239-42. PubMed ID: 17629078 [Abstract] [Full Text] [Related]
18. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers. Noda T, Ohigashi H, Ishikawa O, Eguchi H, Yamada T, Sasaki Y, Yano M, Imaoka S. Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172 [Abstract] [Full Text] [Related]